A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases

Summary

This is a randomized, Phase II study designed to investigate Nimotuzumab plus whole-brain radiation therapy (WBRT)and to compare it rith WBRT alone in patients with brain metastases from non-small cell lung cancer (NSCLC). The purpose of the study is to assess the efficacy of nimotuzumab in combination with WBRT.

Timeline

Start

2009-04

Primary completion

2011-06

Completion

2011-07

Drugs

Indications